Microbial Metabolites Laboratory, Dairy Microbiology Division National Dairy Research Institute, Karnal, 132 001 India.
Indian J Microbiol. 2008 Sep;48(3):317-25. doi: 10.1007/s12088-008-0041-2. Epub 2009 Mar 25.
The genus Enterococcus like other LAB has also been featured in dairy industry for decades due to its specific biochemical traits such as lipolysis, proteolysis, and citrate breakdown, hence contributing typical taste and flavor to the dairy foods. Furthermore, the production of bacteriocins by enterococci (enterocins) is well documented. These technological applications have led to propose enterococci as adjunct starters or protective cultures in fermented foods. Moreover, enterococci are nowadays promoted as probiotics, which are claimed for the maintenance of normal intestinal microflora, stimulation of the immune system and improvement of nutritional value of foods. At the same time, enterococci present an emerging pool of opportunistic pathogens for humans as they cause disease, possess agents for antibiotic resistance, and are frequently armed with potential virulence factors. Because of this "dualistic" nature, the use of enterococci remains a debatable issue. However, based on a long history of safe association of particular enterococci with some traditional food fermentations, the use of such strains appears to bear no particular risk for human health. Abundance of knowledge as well as progress in molecular techniques has, however, enabled exact characterization and safety assessment of strains. Therefore, a balanced evaluation of both, beneficial and undesirable nature of enterococci is required. A clear understanding of their status may, therefore, allow their safe use as a starter, or a probiotic strain. The present review describes the broader insight of the benefits and risks of enterococci in dairy foods and their safety assessment.
肠球菌属与其他 LAB 一样,由于其特定的生化特性,如脂肪分解、蛋白质水解和柠檬酸盐分解,也在乳制品行业中活跃了几十年,从而为乳制品贡献了典型的味道和风味。此外,肠球菌(肠球菌素)产生细菌素的情况已有详细记录。这些技术应用导致肠球菌被提议作为发酵食品中的辅助起始剂或保护培养物。此外,肠球菌如今被推广为益生菌,据称它们可以维持正常的肠道菌群、刺激免疫系统并提高食品的营养价值。同时,由于肠球菌是人类新兴的机会性病原体,因为它们会引起疾病、具有抗生素耐药性的因子,并且经常具有潜在的毒力因子,因此存在争议。由于这种“双重”性质,肠球菌的使用仍然是一个有争议的问题。然而,基于某些特定肠球菌与一些传统食品发酵长期安全相关的历史,使用此类菌株似乎对人类健康没有特别的风险。然而,知识的丰富以及分子技术的进步,使得对菌株进行精确的特征描述和安全性评估成为可能。因此,需要对肠球菌的有益和不良性质进行平衡评估。因此,对其地位的清晰理解可能允许它们作为起始菌株或益生菌菌株安全使用。本综述描述了肠球菌在乳制品中的益处和风险的更广泛认识及其安全性评估。